CURRICULUM VITAE
Robert Dean Davies, M.D.
Present Associate Professor of Psychiatry
Position: Department of Psychiatry
University of Colorado Denver School of Medicine
Office Address: University of Colorado Denver School of Medicine
Department of Psychiatry
13001 E. 17th Place
PO Box 6509, Campus Box F546
Aurora, CO 80045
Telephone: (303) 724-2229
FAX: (303) 724-1399
Date of Birth: June 30, 1963
Haxtun, Colorado
EDUCATION
1989 University of Colorado School of Medicine
Denver, Colorado
Degree: M.D.
1985 University of Colorado
Boulder, Colorado
Degree: B.A. with distinction
POST-GRADUATE TRAINING
1989-1993 General Adult Psychiatry Residency
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
1992-1993 Chief Resident
Department of Psychiatry
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
EMPLOYMENT HISTORY
2011-present Director
4th Year Medical Student Psychiatry Curriculum and Electives Department of Psychiatry University of Colorado Denver School of Medicine
Aurora, Colorado
2006-present Associate Director
Psychiatry Residency Training
University of Colorado Denver School of Medicine
Aurora, Colorado
1999-present Associate Director
Medical Student Education
Department of Psychiatry
University of Colorado Denver School of Medicine
Aurora, Colorado
1998-present Director
Anxiety and Mood Disorders Clinic
Colorado Psychiatric Health
University of Colorado Health Sciences Center
Denver, Colorado
1998-2000 Medical Director
Adult Psychiatry Clinic
Colorado Psychiatric Health
University of Colorado Health Sciences Center
Denver, Colorado
1998-present Staff Psychiatrist
University of Colorado Health Sciences Center
Department of Psychiatry
Denver, Colorado
1993-1998 Staff Psychiatrist
Adult Outpatient Program
Allegheny University Hospitals – Allegheny General
Department of Psychiatry
Pittsburgh, Pennsylvania
1995-1998 Director
Psychiatry Residency Training Program
Allegheny University of the Health Sciences
MCP¨Hahnemann School of Medicine
Allegheny University Hospitals – Allegheny General
Pittsburgh, Pennsylvania
1994-1995 Associate Director
Psychiatry Residency Training Program
Allegheny University of the Health Sciences
MCP¨Hahnemann School of Medicine
Allegheny University Hospitals – Allegheny General
Pittsburgh, Pennsylvania
1991-1993 On-Call Physician
Lake Shore Hospital
Manchester, New Hampshire
1990-1992 Medical Director
Weekend Impaired Driver Intervention Program
Dartmouth College
Hanover, New Hampshire
CERTIFICATION AND LICENSURE
1998-present Colorado State Board of Medical Examiners, #36946
1993-1998 Pennsylvania MD-050112-L
1994 American Board of Psychiatry and Neurology (Psychiatry), Board Certified
ACADEMIC HONORS
1998 Teacher of the Year
Department of Psychiatry
Allegheny University of the Health Sciences
Allegheny Campus
Allegheny University Hospitals – Allegheny General
1989 Lamport Foundation Research Prize
Department of Psychiatry
University of Colorado School of Medicine
1982 Chancellor’s Scholar
University of Colorado
1981 Regent’s Scholar
University of Colorado
ACADEMIC APPOINTMENTS
2005-present Associate Professor
Department of Psychiatry
University of Colorado Denver School of Medicine
Aurora, CO
1998-2001 Adjunct Assistant Professor
Graduate School of Professional Psychology
University of Denver
Denver, Colorado
1998-2005 Assistant Professor
Department of Psychiatry
University of Colorado School of Medicine
Denver, Colorado
1994-1998 Assistant Professor
Department of Psychiatry
Allegheny University of the Health Sciences
MCP¨Hahnemann School of Medicine
Allegheny Campus
Pittsburgh, Pennsylvania
1993-1994 Instructor
Department of Psychiatry
Medical College of Pennsylvania and Hahnemann University
Allegheny Campus
Pittsburgh, Pennsylvania
1992-1993 Instructor
Department of Psychiatry
Dartmouth Medical School
Hanover, New Hampshire
ACADEMIC AND PROFESSIONAL SOCIETIES
1996-1998 Association of Academic Psychiatry
1994-1998 American Association of Directors of Psychiatric Residency Training
1990-2005 American Psychiatric Association
1985 Phi Beta Kappa
1983-1985 Alpha Epsilon Delta
COMMITTEES
2006-present Residency Education Committee/Education Policy Committee
Department of Psychiatry
University of Colorado Denver School of Medicine
Aurora, Colorado
2004-2007 Faculty Senate
University of Colorado Health Sciences Center
Denver, Colorado
1998-2000 Colorado Multiple Institutional Review Board
University of Colorado Health Sciences Center
Denver, Colorado
1998-2000 Residency Education Committee
Department of Psychiatry
University of Colorado Health Sciences Center
Denver, Colorado
1996-1998 Chairman’s Executive Advisory Committee
Department of Psychiatry
MCP¨Hahnemann University, Allegheny Campus
Pittsburgh, Pennsylvania
1995-1998 Council on Graduate Medical Education
Allegheny General Hospital
MCP¨Hahnemann University, Allegheny Campus
Pittsburgh, Pennsylvania
1994-1998 Residency Education Committee
Department of Psychiatry
MCP¨Hahnemann University, Allegheny Campus
Pittsburgh, Pennsylvania
COMMUNITY SERVICE
1997-1998 Board Member
Pittsburgh Psychoanalytic Foundation
Pittsburgh, Pennsylvania
1993 Director
National Anxiety Disorder Screening Day
Allegheny University Hospitals – Allegheny General
Pittsburgh, Pennsylvania
1993-1997 Director
National Depression Screening Day
Allegheny University Hospitals – Allegheny General
Pittsburgh, Pennsylvania
1981 Founding Board Member
Broomfield Community Theatre
Broomfield, Colorado
EDUCATIONAL ACTIVITIES
2009-present Course Master and Lecturer
Human Sexuality (PGY IV Residents in Psychiatry)
University of Colorado Denver School of Medicine
Aurora, Colorado
2001-present Course Master
Psychiatric Aspects of Literature
University of Colorado Denver School of Medicine
Aurora, Colorado
2000-2002 Course Master and Lecturer
Practical Outpatient Management – Psychopharmacology & Psychotherapy (PGY III Residents in Psychiatry)
University of Colorado Health Sciences Center
Department of Psychiatry
Denver, Colorado
1998-2001 Course Master and Lecturer
Psychopharmacology
University of Denver
Graduate School of Professional Psychology
Denver, Colorado
1993-1998 Course Master and Lecturer
Advanced Topics in Psychotherapy (PGY III & IV Residents in Psychiatry)
MCP¨Hahnemann School of Medicine
Allegheny Campus
Pittsburgh, Pennsylvania
1993-1998 Lecturer
Psychopharmacology for Psychology Interns
MCP¨Hahnemann School of Medicine
Allegheny Campus
Pittsburgh, Pennsylvania
1993-1998 Lecturer
Psychopharmacology Course for Third-Year Medical Students
MCP¨Hahnemann School of Medicine
Allegheny Campus
Pittsburgh, Pennsylvania
1994-1995 Course Master and Lecturer
Introduction to Somatic Therapies (PGY-I Residents in Psychiatry)
MCP¨Hahnemann School of Medicine
Pittsburgh, Pennsylvania
1990 Instructor
Psychopharmacology for Third-Year Medical Students
Dartmouth Medical School
Lebanon, New Hampshire
1991-1992 Small Group Instructor
Psychiatric Interviewing
Dartmouth Medical School
Lebanon, New Hampshire
1990 Small Group Instructor
Abnormal Psychology
Dartmouth College
Hanover, New Hampshire
PRESENTATIONS
July 2011 Bipolar Disorders in Primary Care, University of South Carolina Family Practice Review, Hilton Head, SC
July 2011 Management of Treatment Resistant Depression in Primary Care, University of South Carolina Family Practice Review, Hilton Head, SC
July 2011 Anxiety Disorders, University of South Carolina Family Practice Review, Hilton Head, SC
July 2011 Recognizing and Treating ADHD in Adults, University of South Carolina Family Practice Review, Hilton Head, SC
October 2010 Attention-Deficit Hyperactivity Disorder – Adults: Building Confidence in the Diagnosis and Treatment, American Academy of Family Physicians Scientific Assembly, Denver, CO
June 2010 A Multi-site Trial of OROS-MPH with CBT for Adolescents with ADHD and Substance Use Disorders, Symposium, 72nd Annual Meeting of the College on Problems of Drug Dependence, Scottsdale, Arizona
October 2009 Tolerability, Safety, Abuse & Diversion in Multisite Trial of OROS-MPH vs Placebo in Adolescents with ADHD and SUD, Symposium, 56th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Honolulu, Hawaii
May 2007 Adolescent Substance Abuse Treatment and Traditional Martial Arts: Expanding the Continuum of Care. Division of Substance Dependence Seminar, Department of Psychiatry, University of Colorado School of Medicine, Denver, Colorado
September 2006 Adolescent Substance Abuse Treatment and Traditional Martial Arts. Grand Rounds, Department of Child Psychiatry, University of Colorado School of Medicine, Denver, Colorado
February 2005 Traditional Martial Arts in the Treatment of Substance Abusing Youth: Theoretical Basis and Results of a Pilot Study. Grand Rounds, Department of Psychiatry, University of Colorado School of Medicine, Denver, Colorado
August 2003 Treatment Resistance in Anxiety Disorders. Montana Association of Physician Assistants Annual Meeting, Butte, Montana
November 2002 Diagnosis of Anxiety Disorders. Mental Health Corporation of Denver, Staff Training Seminar, Denver, Colorado
April 2002 Management of Anxiety Disorders in Primary Care. University of Colorado Hospital Outreach CME program, Casper, Wyoming
September 2001 Treatment Resistance in Anxiety Disorders. Grand Rounds, Porter Hospital, Englewood, Colorado
January 2001 Obsessive Compulsive Disorder and OC Spectrum Disorders: Treatment Considerations. Colorado Psychiatric Society’s 31st Annual Mid-Winter Meeting, High Anxiety: An Avalanche of New Ideas in the Treatment of Anxiety Spectrum Disorders, Keystone, Colorado
November 2000 Identification and Treatment of Anxiety and Mood Disorders in Primary Care. Workshop Leader, Family Practice Review, University of Colorado Health Sciences Center, Denver, Colorado
September 2000 Treatment Resistance in Anxiety Disorders. Grand Rounds, Mental Health Corporation of Denver, Denver, Colorado
August 2000 Intractable Character Disorders in Psychotherapy. 26th Annual Psychiatry Conference, Character, Mood, Psychosis: The Treatment of the Refractory Patient, The Given Institute at the University of Colorado, Aspen, Colorado
June 2000 Identification and Treatment of Anxiety and Mood Disorders in Primary Care. Workshop Leader, Family Practice Review, University of Colorado Health Sciences Center, Estes Park, Colorado
April 2000 Treatment of Anxiety Disorders. Medical Grand Rounds, Poudre Valley Hospital, Fort Collins, Colorado
November 1999 Practical Approach to Treatment of Psychiatric Disorders in Women. Issues In Women’s Health Seminar, Boca Raton, Florida
November 1999 Psychotropic Medications in Primary Care. Workshop leader, Annual Family Practice Review, University of Colorado Health Sciences Center, Denver, Colorado
October 1999 Diagnosis and Treatment of Attention Deficit Disorder in Adults. Department of Medicine Grand Rounds, Rose Medical Center, Denver, Colorado
September 1999 Practical Approach to the Treatment of Psychiatric Disorders in Women. Issues In Women’s Health Seminar, Bermuda
June 1999 Pharmacologic Treatment of Anxiety Disorders. Invited Lecturer, Prescriptive Authority – Assessment Course, Metropolitan State College, Denver, Colorado
June 1999 Psychopharmacology in Primary Care. Workshop Leader, Family Practice Review, University of Colorado School of Medicine, Denver, Colorado
April 1999 Comorbid Mood and Anxiety Disorders. Psychiatry and the New Millenium, Denver, Colorado
April 1999 Psychopharmacology of Anxiety Disorders. Invited Lecturer, Regis College, Denver, CO
March 1999 Social Anxiety Disorder: New Treatment Strategies. Grand Rounds, North Dakota School of Medicine & Health Sciences, Grand Fork, North Dakota
October 1997 Diagnosis and Treatment of ADD in Adults. Grand Rounds, St. Francis Medical Center, Pittsburgh, Pennsylvania
November 1995 Panic Disorder in Primary Care. Grand Rounds, Armstrong County Memorial Hospital, Kittanning, Pennsylvania
May 1989 Child Abuse: A review of 28 cases referred to START. Presented at the 18th Annual Symposium on Child Abuse and Neglect. Keystone, Colorado
RESEARCH
Co-Investigator (Paula Riggs, PI)
Bupropion for ADHD in Adolescents with Substance Use Disorders
NIDA R01 DA022284, COMIRB #
Principal Investigator
Martial Arts as Early Intervention for Teen Drug Abuse
NIDA R01 DA018679, COMIRB #05-0681
Medical Co-Lead Investigator (Paula Riggs, PI)
A Randomized Controlled Trial of OROS Methylphenidate in for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents with Substance Use Disorders (SUD)
NIDA U10 DA13716 (Protocol CTN-0028), COMIRB #05-0349
Principal Investigator
A Pilot Study to Evaluate the Effect of Traditional Martial Arts Training on Substance Abuse Treatment for Adolescents
COMIRB #04-0031
Principal Investigator
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating Efficacy and Safety of SB-659746-A and Citalopram in Patients with Major Depressive Disorder
GlaxoSmithKline Protocol SB-659746-A/003, COMIRB #01-755
Co-Investigator (Paula Riggs, PI)
Substance Dependent Teens: Impact of Treating Depression
NIDA R01DA13176, COMIRB #00-240
Principal Investigator
Sustained Efficacy Study of Pregabalin in Patients with Panic Disorder with or without Agoraphobia
Pfizer (Parke-Davis) Protocol #1008-093, COMIRB #00-466
Sub-Investigator
A Six-Week, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of 3 Doses of CP-448,187 (.5, 3, and 10mg) and Fluoxetine in Subjects with Major Depressive Disorder
Pfizer Protocol #A2721002, COMIRB #99-922
Sub-Investigator
A Placebo-Controlled Study of Pregabalin in Patients with Social Phobia
Pfizer (Parke-Davis) Protocol #1008-080, COMIRB #99-427
Sub-Investigator
A Placebo Controlled Study of Pregabalin in Patients with Generalized Anxiety Disorder
Pfizer (Parke-Davis) Protocol #1008-083, COMIRB #99-428
Sub-Investigator
A Multicenter, 10-Week, Randomized, Double-Blind, Placebo-Controlled Flexible Dose Outpatient Study of Sertraline in Children and Adolescents with Major Depressive Disorder
Pfizer Protocol #A0501017, COMIRB #99-964
Sub-Investigator
Olanzapine Added to Mood Stabilizers in the Treatment of Bipolar Disorder
Eli Lilly Protocol F1D-MC-HGFU(a), COMIRB #97-445
Sub-Investigator
Clozaril/Leponex vs. Zyprexa in the Reduction of Suicidality in Patients with Schizophrenia and Schizoaffective Disorder who are at Risk for Suicide
Novartis Protocol ABA 451, COMIRB #98-132
Sub-Investigator
Fluoxetine vs. Placebo in Post-Traumatic Stress Disorder
Eli Lilly Protocol B1Y-MC-HCJL, IRB #98-404
Sub-Investigator
A Placebo-Controlled Study of Pregabalin and Lorazepam in Patients with Generalized Anxiety Disorder
Parke-Davis Protocol 1008-026, IRB #98-321
Sub-Investigator
A 12-Week Double-Blind, Fixed Dose Comparison of 20 and 40 mg Daily of Paroxetine and Placebo in patients Suffering From Post-Traumatic Stress Disorder
SmithKline-Beecham Protocol SB29060/651, IRB #98-876.
Sub-Investigator
A Double-Blind, Randomized Trial of Three Fixed Doses of Transdermal Buspirone Compared to Placebo in the Treatment of Anxious Patients
Bristol-Meyers Squibb Protocol CN101-094-[15], IRB #RC-2231.
PUBLICATION
Riggs P, Winhusen T, Davies R, et al (2011). Randomized Controlled Trial of Osmotic-Release Methylphenidate with Cognitive-Behavioral Therapy in Adolescents with Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders. Accepted for publication. Journal of American Academy of Child & Adolescent Psychiatry
Winhusen T, Lewis D, Riggs P, Davies RD, Adler L, Sonne S, Somoza E (2011). Subjective Effects, Misuse, and Adverse Effects of Osmotic-Release Methylphenidate Treatment in Adolescent Substance Abusers with Attention Deficit Hyperactivity Disorder (ADHD). Accepted for publication. Journal of Child and Adolescent Psychopharmacology
Davies R (2009), Review of Adolescent Substance Abuse: Psychiatric Co-Morbidity and High Risk Behaviors by Yifrah Kaminer and Oscar G. Bukstein. American Journal of Psychiatry 166:117.
Davies R and Riggs PD (2007). “Integrated Treatment of Substance Use Disorders and Co-Occurring Psychiatric Disorders in Adolescents.” Chapter 20 in: E. Gilvarry, P. McArdle (Eds.), Alcohol, Drugs, and Young People: Clinical Approaches. London, UK: Mac Keith Press, pp 225-234.
Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK (2007). A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents with Major Depression, Behavior Problems, and Substance Use Disorders. Archives of Pediatric and Adolescent Medicine, 161(11): 1026-1034
Davies RD, Thurstone C, Woyewodzic K (2004). Substance Use Disorders and Neurologic Illness. Current Treatment Options in Neurology 6(5): 423-432
Davies RD, Chapman MM, Hall SK, Mikulich SK, Riggs PD (2002). Correlates of social phobia in depressed adolescents with conduct disorder and substance dependence. Drug and Alcohol Dependence 66: S41
Dubovsky S, Davies R, Dubovsky A (2002). “Mood Disorders.” In: Hales RE, Yudofsky SC, Talbott JA (Eds). American Psychiatric Press Textbook of Psychiatry, Fourth Edition. Washington, DC: American Psychiatric Press.
Riggs PD and Davies RD (2002). A Clinical Approach to Integrating Treatment for Adolescent Depression and Substance Abuse. Journal of the Academy of Child and Adolescent Psychiatry 41(10):1253-1255
Davies RD, Gabbert SL, Riggs PD (2001). Anxiety Disorders in Neurologic Illness. Current Treatment Options in Neurology 3(4): 333-346
Davies RD, Dubovsky SL, Gabbert S, Chapman M (2001). Treatment Resistance in Anxiety Disorders. Bulletin of the Menninger Clinic 64(3 suppl. A): A22-A36
Davies RD, Winter L (2001). “Generalized Anxiety Disorder,” In: Psychiatric Secrets, 2nd Edition. J. Jacobson, M.D. and A. Jacobson, M.D. (Eds.)
Davies RD (2001). “Social Phobias and Specific Phobias.” In: Psychiatric Secrets, 2nd Edition.
J. Jacobson, M.D. and A. Jacobson, M.D. (Eds.)